S&P 500 Futures
(-0.01%) 5 046.75 points
Dow Jones Futures
(0.00%) 38 469 points
Nasdaq Futures
(-0.07%) 17 338 points
Oil
(0.21%) $83.02
Gas
(-0.34%) $1.785
Gold
(-1.35%) $2 314.80
Silver
(-1.54%) $26.83
Platinum
(-1.36%) $918.60
USD/EUR
(0.09%) $0.939
USD/NOK
(0.14%) $11.00
USD/GBP
(0.05%) $0.810
USD/RUB
(-0.16%) $93.26

Realtime updates for Ovoca Bio PLC [OVB.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated22 Apr 2024 @ 12:06

-7.69% £ 0.600

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 12:06):

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions...

Stats
Today's Volume 400 588
Average Volume 166 736
Market Cap 489 383
EPS £-0.00590 ( 2019-06-29 )
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -0.300
ATR14 £0 (0.00%)

Ovoca Bio PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ovoca Bio PLC Financials

Annual 2022
Revenue: £0
Gross Profit: £0 (0.00 %)
EPS: £-0.0688
Q2 2023
Revenue: £0
Gross Profit: £-106 027 (0.00 %)
EPS: £-0.0255
Q4 2022
Revenue: £0
Gross Profit: £-269 210 (0.00 %)
EPS: £0.000400
Q2 2019
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.00480

Financial Reports:

No articles found.

Ovoca Bio PLC

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators